Covid-19: Johnson & Johnson applies for emergency use of vaccine from ANVISA

The agency's goal is to complete the approval analysis within seven working days, discounting time that the process may be suspended awaiting further information from the manufacturer.

RIO DE JANEIRO, BRAZIL - Brazil's National Health Regulatory Agency (ANVISA) advised that it received, this Wednesday, 24th, the request for emergency use of the vaccine from Janssen, the pharmaceutical arm of Johnson & Johnson.

The regulator has already started the screening of the documents presented in the request.

The first 24 hours will be used to screen the file and verify that the necessary documents are available. If there is important information missing, ANVISA "may request the additional information from the laboratory."

To make its evaluation, ANVISA will use the information submitted along with the application and also the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?